ÀÏÂ÷Áø·á¸¦ À§ÇÑ ´ç´¢º´ ¸Å´º¾ó
- ÀúÀÚ(±Û)ÀÌÇöö
- ÃâÆÇ»ç°í·ÁÀÇÇÐ
- ¹ßÇàÀÏ2015 ³â 11¿ù 10ÀÏ
´Ù¾çÇÑ Áø·á°æÇè°ú ¿¬±¸¸¦ ÅëÇÑ ´ç´¢º´ ¸ÂÃãÄ¡·á
| Á¦ ¸ñ | ´ç´¢º´¹é°ú |
|---|---|
| ÃâÆÇ»ç | ÇöÁ¸ |
| ¹ßÇàÀÏ | 2017 |
| Á¦ ¸ñ | ÀÏÂ÷Áø·á¸¦ À§ÇÑ ´ç´¢º´ ¸Å´º¾ó |
|---|---|
| ÃâÆÇ»ç | °í·ÁÀÇÇÐ |
| ¹ßÇàÀÏ | 2015 |
| Á¦ ¸ñ | ³ª Ȧ·Î Áö±¸ÃÌ ¿ÀÁö¿©Çà |
|---|---|
| ÃâÆÇ»ç | ¿©ÇึÀεå |
| ¹ßÇàÀÏ | 2015 |
| Á¦ ¸ñ | ´ç´¢º´ÇÐ |
|---|---|
| ÃâÆÇ»ç | °í·ÁÀÇÇÐ |
| ¹ßÇàÀÏ | 2005 |
| Á¦ ¸ñ | ¼¼·ÎÅä´Ñ°ú ¼ö¿ëüÀDZâÃÊ¿ÍÀÓ»ó |
|---|---|
| ÃâÆÇ»ç | ¼¼·ÎÅä´Ñ¿¬±¸È¸ |
| ¹ßÇàÀÏ | 2005 |
| Á¦ ¸ñ | ½ÅÀåÀ̽Ä-À̷аú½ÇÁ¦- |
|---|---|
| ÃâÆÇ»ç | ÀÇÇй®È»ç |
| ¹ßÇàÀÏ | 2004 |
| Á¦ ¸ñ | Association between Metformin Use and Risk of Lactic Acidosis or Elevated Lactate Concentration in Type 2 Diabetes |
|---|---|
| ¹ßÇ¥³âµµ | 2017 |
| ¹ßÇ¥Áö | Yonsei Med J |
| Á¦ ¸ñ | Association Between Heme Oxygenase-1 Promoter Polymorphisms and the Development of Albuminuria in Type 2 Diabetes: A Case-Control Study |
|---|---|
| ¹ßÇ¥³âµµ | 2015 |
| ¹ßÇ¥Áö | Medicine (Baltimore) |
| Á¦ ¸ñ | The glycated albumin to glycated hemoglobin ratio might not be associated with carotid atherosclerosis in patients with type 1 diabetes |
|---|---|
| ¹ßÇ¥³âµµ | 2014 |
| ¹ßÇ¥Áö | Diabetes Metab J |
| Á¦ ¸ñ | Inverse association between glycated albumin and insulin secretory function may explain higher levels of glycated albumin in subjects with longer duration of diabetes |
|---|---|
| ¹ßÇ¥³âµµ | 2014 |
| ¹ßÇ¥Áö | PLoS One |
| Á¦ ¸ñ | Tolerability, effectiveness and predictive parameters for the therapeutic usefulness of exenatide in obese, Korean patients with type 2 diabetes |
|---|---|
| ¹ßÇ¥³âµµ | 2014 |
| ¹ßÇ¥Áö | J Diabetes Investig |
| Á¦ ¸ñ | Postprandial C-peptide to glucose ratio as a predictor of ¥â-cell function and its usefulness for staged management of type 2 diabetes |
|---|---|
| ¹ßÇ¥³âµµ | 2014 |
| ¹ßÇ¥Áö | J Diabetes Investig |
| Á¦ ¸ñ | Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice |
|---|---|
| ¹ßÇ¥³âµµ | 2014 |
| ¹ßÇ¥Áö | Metabolism |
´ç´¢º´ÀÇ ¿øÀÎÀ» ±Ô¸íÇϰí ÇÕº´ÁõÀ» ¿¹¹æÇÒ ¼ö ÀÖ´Â Ä¡·áÁ¦ °³¹ßÀ» À§ÇØ ²÷ÀÓ¾øÀÌ Å½±¸ÇÏ°í ¿¬±¸Çϰí ÀÖ½À´Ï´Ù.
Áø·á¿¡ ÀÖ¾î¼ °¡Àå Áß¿äÇÑ °ÍÀº ȯÀÚ¿ÍÀÇ ¼ÒÅë°ú ÀÌÇØ, ±×¸®°í ½Å·ÚÀÔ´Ï´Ù. ȯÀÚ ÇÑ ºÐ ÇÑ ºÐÀÇ ÀÛÀº º¯È³ª ºÒÆíÇÔÀ» µè°í ±× ºÐÀÇ »óÅÂ¿Í »óȲÀ» ±íÀÌ ÀÌÇØÇÏ¿© Á¤È®ÇÑ Áø´ÜÀ» ³»¸®°í, ȯÀÚ Áß½ÉÀÇ ¸ÂÃã Ä¡·á°èȹÀ» ¼¼¿ì°í, ÇÔ²² Áö¼ÓÀûÀÎ °ü¸®¸¦ ÇØ³ª°¡´Â °ÍÀÌ Áß¿äÇÏ´Ù°í »ý°¢ÇÕ´Ï´Ù.
30¿©³â°£ ¼ö¸¹Àº ´ç´¢º´ ȯÀÚµéÀ» Áø·áÇÏ¸é¼ ¾òÀº °æÇè°ú ´Ù¾çÇÑ ¿¬±¸ ¼º°ú¸¦ ¹ÙÅÁÀ¸·Î °³°³Àο¡°Ô ¸Â´Â ¸ÂÃãÇü Ä¡·á¸¦ Á¦°øÇϰí ÇÕº´ÁõÀ» ¿¹¹æÇÏ¿© ȯÀںеéÀÇ »îÀÇ ÁúÀ» ³ôÀ̱â À§ÇØ ÃÖ¼±À» ´ÙÇϰڽÀ´Ï´Ù.

¿¬¼¼ÀÌÇöö³»°ú´Â ´ç´¢º´, °íÇ÷¾Ð, °ñ´Ù°øÁõ, °íÁöÇ÷Áõ, °©»ó¼± µî ³»ºÐºñÁúȯÀ» ÁßÁ¡ÀûÀ¸·Î Áø·áÇÏ´Â ÀÇ¿øÀ¸·Î ´ç´¢º´ ºÐ¾ß ¸íÀÇ·Î ¾Ë·ÁÁø ÀÌÇöö ±³¼ö°¡ ¿¬¼¼ÀÇ´ë ÅðÀÓ ÈÄ 2015³â¿¡ °³¿øÇÏ¿´½À´Ï´Ù. ¼¼ºê¶õ½ºº´¿ø¿¡¼ 30¿©³â°£ ³»ºÐºñ³»°ú ±³¼ö·Î ÀçÁ÷ÇÏ¸ç ½×Àº ´Ù¾çÇϰí dzºÎÇÑ Áø·á°æÇè°ú Àü¹®ÀûÀÎ Áö½ÄÀ¸·Î ȯÀÚ ÇÑ ºÐ ÇÑ ºÐ ÃÖ¼±À» ´ÙÇØ Áø·áÇÕ´Ï´Ù.
¼¿ïƯº°½Ã ¸¶Æ÷±¸ ¼°·Î 133, º´¿ìºôµù 4Ãþ